Login
$EYPT
$0.36 -$0.00 (0.68%) Close

$EYPT 3 SEC Filings

Filed On Filing
08 Jan 2025 Form 3: Sanders Reginald J., Director

No securities owned

05 Sep 2024 Form 3: Hassan Fred, Director

No securities owned

22 Apr 2024 Form 3: Adage Capital Management, L.p., 10% owner and 2 others

Holds 5,156,299 shares of Common Stock, par value $0.001 per share ("Common Stock")

04 Mar 2024 Form 3: Ribeiro Ramiro, Chief Medical Officer

No securities owned

06 Dec 2023 Form 3: Cormorant Asset Management, Lp, 10% owner and 2 others

Holds 3,530,943 shares of Common Stock

17 Oct 2023 Form 3: Duty Stuart, Director

No securities owned

13 Jul 2022 Form 3: Zaderej Karen L., Director

No securities owned

27 Jun 2022 Form 3: Adamis Anthony P, Director

No securities owned

14 Jan 2022 Form 3: Pine Michael Craig, Chief Corp Dev.&Strat. Officer

No securities owned

03 Nov 2021 Form 3: Duker Jay S., Chief Operating Officer

Holds 5,657 shares of Common Stock

14 Jan 2021 Form 3: OcuMension Therapeutics, 10% owner

Holds 3,010,722 shares of Common Stock, $0.001 par value

13 Jan 2021 Form 3: Liu Ye, Director

Holds 3,010,722 shares of Common Stock, $0.001 par value

18 Nov 2019 Form 3: Elston George, Chief Financial Officer

No securities owned

16 Jul 2019 Form 3: Dicicco Wendy F, Director

No securities owned

12 Jun 2019 Form 3: Jones David Scott, SVP & Chief Commercial Officer

No securities owned

29 Jan 2019 Form 3: Guyer David R, Director

No securities owned

29 Oct 2018 Form 3: Landis John B., Director

No securities owned

03 Aug 2018 Form 3: Price David, Chief Financial Officer

No securities owned

27 Jun 2018 Form 3: Ando Goran, Director

No securities owned

16 May 2018 Form 3: Blum Leonard M, See Remarks

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support